PrognosiX AI is here.
The next generation of X-Ray AI powered by PrognosiX. We're inviting licensed dental professionals to evaluate it on study cases during FDA review.
PrognosiX AI is an investigational device. It is not FDA cleared, not for sale, and not for diagnostic use or patient care.
Works with all
PrognosiX AI works with CBCT companies around the world.
Help shape the future of dental imaging
Participate in the study and provide feedback on our investigational AI software. Participants receive onboarding support.
Be first to explore PrognosiX AI.
We're inviting a select group of licensed dental professionals to get an early, hands-on look at PrognosiX AI's 3D pulp-tissue segmentation. Explore the technology on study cases, help shape where it goes, and sharpen your CBCT eye. It's evaluation-only, and there's no cost to join.
See pulp tissue in 3D
Explore how PrognosiX AI reconstructs and segments dental pulp tissue in three dimensions from a CBCT volume, not just flat slices.
Help shape the technology
Your structured feedback on study cases directly informs how PrognosiX AI develops. Early participants have the biggest say in where it goes.
Sharpen your CBCT eye
Put in real reps with 3D pulp-tissue anatomy on study cases, for a genuine learning experience on your schedule.
From raw scan to segmented pulp-tissue visualization in seconds
PrognosiX processes CBCT DICOM study cases through an AI pipeline in seconds.
Simple from the Start
No software to install. No IT setup. Upload a study case from any browser and PrognosiX AI handles the rest: processing, pulp-tissue segmentation, and delivery in seconds.
See It in Action
Explore segmented pulp-tissue anatomy on study cases in the evaluation environment, the same view study participants work with.
Secure by Design
Built with end-to-end encryption and privacy safeguards throughout the study pipeline.
Works Anywhere in the World
Cloud-native and browser-based: any country, any device. No local software or hardware required.
Working Toward FDA Clearance
PrognosiX is in active development and pursuing FDA clearance for software that segments dental pulp tissue on CBCT images. It is not yet FDA cleared and is not available for sale.
Dental Advisory Board
Built with input from practicing dental professionals across every major discipline, guiding the study's design and evaluation, and grounding its education emphasis in real-world feedback.
Dr. Amir Guirguis
DDS · General Dentistry
Practicing in Ohio and Florida, Dr. Guirguis advises on the study's design and on making pulp-tissue visualization an approachable learning experience for general dentists.
Dr. Edward J. Zuckerberg
DDS FAGD · Digital Dentistry
CDO at Viome and a digital dentistry advocate. Advises on the study's design and on how participants engage with study cases.
Dr. Eric Guirguis
DDS MS · Periodontology & Implants
Based in Westlake, OH, Dr. Guirguis advises on the study's evaluation of how pulp-tissue anatomy is visualized on study cases.
Dr. Karim Kamel
DDS · Prosthodontics & Digital AI
A CDO and digital dentistry delegate, Dr. Kamel advises on the study's design and on the educational value of reviewing pulp-tissue anatomy.
Dr. Nakul Rathi
DDS · Prosthodontics & Implants
Houston-based prosthodontist. Advises on the study's evaluation of pulp-tissue visualization on study cases.
Dr. Nidhi Shah
DDS · General & Diagnostic Dentistry
Specializes in restorative and diagnostic dentistry, bringing a patient-centered perspective to the study's design and evaluation.
Dr. Tony Tran
DDS · Oral Surgery, Implants & Teledentistry
Houston-based clinician. Advises on the study's design and on how participants evaluate pulp-tissue anatomy on study cases.
Dr. Yelisbet Fernandez
DDS · General & Aesthetic Dentistry
Miami-based clinician. Advises on the study's participant experience and its educational framing.
See PrognosiX AI in action.
Explore joining the study. We'll show you what participating involves and how PrognosiX AI segments pulp-tissue anatomy on study cases.
Study participation includes
- Works with all major CBCT scanners
- Encryption & privacy safeguards
- White-glove onboarding & direct support
- No cost to participate in the study